‘Bet hedging’ explains the efficacy of many combination cancer therapies

The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study.Read the Original Article

Receive Updates

No spam guarantee.

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar